Flare Therapeutics

Flare Therapeutics is a biotechnology company that deciphers the biology of transcription factors with a novel approach to develop small molecule drugs, thereby opening up new therapeutic areas. Based on insights from the pioneering work of its scientific founders, the Flare team has discovered "switch sites," which are druggable regions critical for transcription factor regulation to address disease-causing mutations. Our drug discovery targeting these switch points has rapidly advanced, leading to a new pipeline of drug programs focused on well-validated transcription factors, initially concentrating on precision oncology, with potential developments in neurology, rare genetic disorders, immunology, and inflammation.